ARTICLE | Financial News
OptiNose raises $37M in series D round
May 9, 2017 8:16 PM UTC
OptiNose Inc. (Yardley, Pa.) raised $37 million in a series D round led by Fidelity Management & Research Company. Avista Capital Partners, Entrepreneurs Fund and existing investors also participated.
OptiNose's lead candidate OPN-375 is under FDA review to treat nasal polyposis in adults. Its PDUFA date is in September...
BCIQ Company Profiles
BCIQ Target Profiles